CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2018-08-21
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the longterm impact on cardiovascular morbidity and
mortality, relevant efficacy parameters (e.g., glycaemic parameters) and safety (e.g., weight
and hypoglycaemia) of treatment with linagliptin in patients with type 2 diabetes at elevated
cardiovascular risk receiving usual care, and compare outcome against glimepiride.